Rewriting the MASLD‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism
Abstract Abnormal epigenetic patterns are crucial for the progression of metabolic‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) development. Recent research focused on the interplay between epigenetics and altered metabolic pathways in HCC from MASLD, suggesting that the reversibility of epigenetic changes offers ...
Chiara Aiello+7 more
wiley +1 more source
Liver-related outcomes in patients with cirrhosis: The value of clinical and laboratory data and noninvasive tests. [PDF]
Albhaisi S+4 more
europepmc +1 more source
Mitochondrial dysfunction: Related diseases, influencing factors, and detection
Mitochondrial dysfunction is implicated in the pathogenesis of numerous diseases, including neurological disorders, cancers, and cardiovascular conditions, through mechanisms such as mitochondrial DNA mutations, dysregulation of mitochondrial network dynamics, and impaired mitophagy.
Zhaojin Li+9 more
wiley +1 more source
ABSTRACT Drug‐induced liver injury (DILI) is a serious adverse event and a common cause of postmarketing drug withdrawal. Despite nonclinical assessments of DILI risk, which are predominantly conducted in experimental animals, DILI remains a frequent adverse event, highlighting the need to improve nonclinical assessments.
Xingming Liu+7 more
wiley +1 more source
Association between the red blood cell distribution width-platelet ratio and the risk of in-hospital mortality in patients with alcoholic liver cirrhosis (with or without severe liver disease): a retrospective cohort study based on the MIMIC-IV database. [PDF]
Dai J, Li B, Shui P, Xia B, Liu N.
europepmc +1 more source
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai+8 more
wiley +1 more source
Cystatin C as a predictor of renal recovery and in hospital mortality in patients with acute kidney injury and liver cirrhosis. [PDF]
Nagy E+3 more
europepmc +1 more source
Saliva as a TDM matrix and its application in the model‐informed precision dosing
Abstract This study reviews the main points of saliva as a therapeutic drug monitoring (TDM) matrix, its advantages and limitations, the methods of saliva sample collection and testing, the types of drugs in saliva TDM, and the methods of establishing saliva population pharmacokinetic (Pop PK) models, as well as summarizes the experiences and ...
Baohua Xu+9 more
wiley +1 more source
The Heart of the Matter: A Case of Massive Pedal Edema Erroneously Attributed to Liver Cirrhosis. [PDF]
Nekkanti A+4 more
europepmc +1 more source
ABSTRACT Background Shear wave elastography (SWE) is an emerging noninvasive imaging technique for assessing liver fibrosis. This meta‐analysis aimed to evaluate the diagnostic accuracy of SWE compared to conventional imaging techniques. Methods A systematic search was conducted in PubMed, Embase, Cochrane Library, and Web of Science databases.
Bijuan Hu, Zhiping Huang, Liyin Huang
wiley +1 more source